STE STERIS Plc

STERIS Expands Healthcare Consumables Offering with Acquisition of Key Surgical for approximately $850 million

STERIS Expands Healthcare Consumables Offering with Acquisition of Key Surgical for approximately $850 million
EN
06/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STERIS Plc

 PRESS RELEASE

STERIS Announces Financial Results for Fiscal 2026 Second Quarter 

STERIS Announces Financial Results for Fiscal 2026 Second Quarter  Total revenue from continuing operations increased 10%; constant currency organic revenue grew 9%As reported EPS from continuing operations increased to $1.94; adjusted EPS increased to $2.47Fiscal 2026 constant currency organic revenue, EPS and free cash flow outlook increased DUBLIN, IRELAND , Nov. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 second quarter ended September 30, 2025. Total revenue from continuing operations for the ...

 PRESS RELEASE

STERIS Announces Dividend of $0.63 per share

STERIS Announces Dividend of $0.63 per share DUBLIN, IRELAND, Oct. 29, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on December 18, 2025, to shareholders of record at the close of business on November 18, 2025.   Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at -ir.com. STERIS is a leading global provider of products and services that support patient care with an emphasis on infec...

 PRESS RELEASE

STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Result...

STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025 DUBLIN, IRELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 second quarter results at 9:00 a.m. ET on November 6, 2025. The conference call can be heard live at or via phone by dialing 1-800-715-9871 in the United States or 1-646-307-1963 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial results will be issued after the...

 PRESS RELEASE

STERIS Announces Chief Financial Officer Transition

STERIS Announces Chief Financial Officer Transition Long-time CFO Michael J. Tokich to be succeeded by Karen L. Burton,  Chief Accounting Officer DUBLIN, IRELAND, Aug. 06, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that Michael J. Tokich, Senior Vice President and Chief Financial Officer (CFO), is stepping down from his role following seventeen years as CFO. The transition from Tokich to Karen L. Burton, currently Vice President and Chief Accounting Officer (CAO), will occur on August 18, 2025. Thereafter, Tokich will become Senior Finan...

 PRESS RELEASE

STERIS Announces Financial Results for Fiscal 2026 First Quarter

STERIS Announces Financial Results for Fiscal 2026 First Quarter Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations increased to $1.79; adjusted EPS increased to $2.34Fiscal 2026 revenue and free cash flow outlook updated DUBLIN, IRELAND, Aug. 06, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 first quarter ended June 30, 2025. Total revenue from continuing operations for the first quarter of fiscal 2026 increased 9%...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch